Who is sponsoring NCT05013723?

NCT05013723 is sponsored by Intermountain Health Care, Inc..

What drugs are being tested in NCT05013723?

Interventions in NCT05013723: Surveys.

What condition does NCT05013723 study?

NCT05013723 studies Post-acute COVID-19 (PACS), or "long COVID" Syndrome.

Is NCT05013723 still recruiting?

NCT05013723 is currently completed. Last updated 7 November 2024.

Last reviewed 2024-11-07 · How we verify

NCT05013723: MAbPACs

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Monoclonal Antibody Treatment on Post-Acute COVID-19 Syndrome

Completed Last updated 7 November 2024

What this trial tests

trial testing Surveys in Post-acute COVID-19 (PACS), or "long COVID" Syndrome in 260 participants. Completed in 16 December 2022.

Timeline

30 August 2021

Primary endpoint
16 December 2022

16 December 2022

Quick facts

Lead sponsor	Intermountain Health Care, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	260
Start date	30 August 2021
Primary completion	16 December 2022
Estimated completion	16 December 2022
Sites	1 location across United States

Drugs / interventions tested

Surveys

Conditions studied

Post-acute COVID-19 (PACS), or "long COVID" Syndrome — all drugs for Post-acute COVID-19 (PACS), or "long COVID" Syndrome →

Sponsor

Intermountain Health Care, Inc. — full company profile →

Who can join

18 and older, any sex, with Post-acute COVID-19 (PACS), or "long COVID" Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Use the Intermountain real-world MAb-treatment registry and control group to prospectively evaluate PACS symptoms at least 60 days after initial COVID-19 diagnosis.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Post-COVID-19 condition: clinical phenotypes, pathophysiological mechanisms, pathology, and management strategies.
Vlaming-van Eijk LE, Tang G, Bourgonje AR, den Dunnen WFA, et al · · 2025 · cited 5× · PMID 40492581 · DOI 10.1002/path.6443
Long- und Post-COVID: Was bisher bekannt ist.
Trinkmann F, Herth FJF. · · 2022 · PMID 36258815 · DOI 10.1007/s11298-022-3010-x
Long- und Post-COVID im Fokus.
Trinkmann F, Herth FJF. · · 2022 · PMID 35440855 · DOI 10.1007/s41906-022-1258-0
Long- und Post-COVID: Was bisher zum Krankheitsbild bekannt ist.
Trinkmann F, Herth FJF. · · 2022 · PMID 35194468 · DOI 10.1007/s15033-022-2804-6

Verify or expand the search:

Other trials of Surveys

Trials testing the same drug.

NCT07407686 — Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services · not yet recruiting
NCT07137468 — Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk · recruiting
NCT07010081 — Using Digital Health in a Postoperative Setting After Major Surgery: Survey Study · NA · recruiting
NCT06962995 — Multi-Cancer Detection Observational Cohort Study · recruiting
NCT06960499 — Predictors of Physical Activity in Adult Patients With Hemophilic Arthropathy · not yet recruiting

Other Intermountain Health Care, Inc. trials

Trials by the same sponsor.

NCT07334795 — Intermountain Stewardship in Community Outpatient Settings-Resources & Engagement-Pediatrics · active not recruiting
NCT07348289 — PIVO Use for Blood Cultures in the Emergency Department · recruiting
NCT06865781 — Vital Signs Reduction Study · NA · active not recruiting
NCT05936021 — Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease U · NA · unknown
NCT05141396 — Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05013723 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Intermountain Health Care, Inc.
Last refreshed: 7 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05013723.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing